Preclinical models of bone metastases

Area of Science:

• Oncology
• Pharmacology
• Translational Research

Background:

• Bisphosphonates are clinically used for bone metastases in malignant diseases.
• The exact mechanisms of metastasis and bisphosphonate action remain incompletely understood.
• Emerging clinical data suggest potential anticancer properties of bisphosphonates.

Purpose of the Study:

• To review advancements in animal models for studying bone metastasis.
• To highlight how these models can elucidate bisphosphonate mechanisms and inform clinical trial design.

Main Methods:

• Discussion of established and novel animal models for osteolytic and osteoblastic metastasis.
• Focus on mouse models, including heart injection and orthotopic models.
• Mention of recent developments in myeloma and breast cancer metastasis models.

Main Results:

• The orthotopic mouse model offers a more comprehensive representation of metastasis compared to the heart injection model.
• Specific mouse models have been developed to study osteoblastic metastasis using human breast cancer cells.
• New, promising animal models for myeloma research have been introduced.

Conclusions:

• Advanced animal models are crucial for understanding metastasis and bisphosphonate mechanisms.
• These models will facilitate the elucidation of drug action and guide future clinical trial development.
• Further research using these models is expected to enhance bisphosphonate therapy for bone metastases.